Concepedia

Publication | Closed Access

Escalation to natalizumab or switching among immunomodulators in relapsing multiple sclerosis

93

Citations

30

References

2011

Year

Abstract

We suggest that an escalation to natalizumab is more effective than switching among immunomodulators in RRMS patients who failed a first-line treatment.

References

YearCitations

Page 1